Umesh Mishra - Aug 29, 2022 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
Chief Technology Officer, Director
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Stock symbol
TGAN
Transactions as of
Aug 29, 2022
Transactions value $
$0
Form type
4
Date filed
8/31/2022, 04:06 PM
Previous filing
Jan 4, 2022
Next filing
Nov 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TGAN Stock Option (right to buy) Award $0 +1.56K $0.00 1.56K Aug 29, 2022 Common Stock 1.56K $5.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-twelfth (1/12) of the shares subject to the option will vest in equal monthly installments over the following year, subject to the Reporting Person's continued service as of each such vesting date.